BioAffinity Technologies Shares Slide Amid Dilutive Offering Details

BioAffinity Technologies shares are trading lower after the company announced a private placement and warrant inducement transaction, raising $1.2 million but diluting existing shareholders due to the issuance of convertible preferred stock and warrants.